Brief: Medison Pharma Announces Approvals By Health Canada And Therapeutics Goods Administration Of Kimmtrak® (Tebentafusp) For Treatment Of Unresectable Or Metastatic Uveal Melanoma

Immunocore Holdings

08/06/2022 16:48

June 8 (Reuters) - Medison Pharma :
    * MEDISON PHARMA ANNOUNCES APPROVALS BY HEALTH CANADA AND
THERAPEUTICS GOODS ADMINISTRATION OF KIMMTRAK® (TEBENTAFUSP) FOR
TREATMENT OF UNRESECTABLE OR METASTATIC UVEAL MELANOMA

Source text for Eikon:  ID:nCNWG2nBGa 
Further company coverage:  IMCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))